KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Net Income (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36.46%
Dec 31, 2025 -58.55%
Sep 30, 2025 124.58%
Jun 30, 2025 -17.23%
Mar 31, 2025 175.92%
Dec 31, 2024 -77.84%
Sep 30, 2024 279.36%
Jun 30, 2024 760.18%
Mar 31, 2024 -114.73%
Dec 31, 2023 -55.66%
Sep 30, 2023 25.45%
Jun 30, 2023 -51.46%
Mar 31, 2023 75.80%
Dec 31, 2022 -24.59%
Sep 30, 2022 62.72%
Jun 30, 2022 -10.77%
Mar 31, 2022 -22.27%
Dec 31, 2021 0.80%
Sep 30, 2021 306.03%
Jun 30, 2021 -71.81%
Mar 31, 2021 1.92%
Dec 31, 2020 -20.09%
Sep 30, 2020 12.09%
Jun 30, 2020 -1.21%
Mar 31, 2020 7.16%
Dec 31, 2019 -13.47%
Sep 30, 2019 -9.68%
Jun 30, 2019 9.39%
Mar 31, 2019 3.32%
Dec 31, 2018 3.71%
Sep 30, 2018 -19.03%
Jun 30, 2018 -0.65%
Mar 31, 2018 154.20%
Dec 31, 2017 -310.98%
Sep 30, 2017 -6.04%
Jun 30, 2017 3.86%
Mar 31, 2017 7.03%
Dec 31, 2016 -4.07%
Sep 30, 2016 7.86%
Jun 30, 2016 -1.58%
Mar 31, 2016 5.56%
Dec 31, 2015 -3.38%
Sep 30, 2015 12.70%
Jun 30, 2015 1.85%
Mar 31, 2015 25.43%
Dec 31, 2014 4.02%
Sep 30, 2014 -19.59%
Jun 30, 2014 44.18%
Mar 31, 2014 5.09%
Dec 31, 2013 -25.37%
Sep 30, 2013 8.74%
Jun 30, 2013 -12.27%
Mar 31, 2013 81.98%
Dec 31, 2012 -28.82%
Sep 30, 2012 -12.56%
Jun 30, 2012 6.93%
Mar 31, 2012 26.77%
Dec 31, 2011 105.73%
Sep 30, 2011 -61.20%
Jun 30, 2011 4.00%
Mar 31, 2011 10.08%
Dec 31, 2010 -17.31%
Sep 30, 2010 2.83%
Jun 30, 2010 3.00%
Mar 31, 2010 25.35%
Dec 31, 2009 -32.83%
Sep 30, 2009 9.22%
Jun 30, 2009 24.53%